Deferred Tax Assets, Valuation Allowance of BIOADAPTIVES, INC. from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BIOADAPTIVES, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • BIOADAPTIVES, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $718,837, a 23% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

BIOADAPTIVES, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $718,837 +$133,670 +23% 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q4 2023 $585,167 +$59,955 +11% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q4 2022 $525,212 +$99,116 +23% 31 Dec 2022 10-K 10 Apr 2024 2023 FY
Q4 2021 $426,096 +$155,988 +58% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $270,108 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2015 $959,189 +$77,327 +8.8% 31 Dec 2015 10-K 14 Apr 2016 2015 FY
Q4 2014 $881,862 +$886,432 31 Dec 2014 10-K 14 Apr 2016 2015 FY
Q4 2013 $4,570 31 Dec 2013 10-K 14 Apr 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.